First Cigarette That “Helps You Smoke Less” Launches National Pilot in Chicagoland
VLN® Reduced Nicotine Content Cigarettes Launch in Chicagoland Pilot VLN® 95% reduced nicotine content cigarettes…
Month: April 2022
Renibus Therapeutics Strengthens IP Position with Additional US Patent
Renibus Therapeutics granted patent approval for the novel aqueous iron composition of RBT-3, a product…
aTyr Pharma Announces FDA Orphan Drug Designation for Efzofitimod (ATYR1923) for Treatment of Systemic Sclerosis
Second U.S. orphan drug designation for efzofitimod clinical program SAN DIEGO, April 13, 2022 (GLOBE…
Aquestive Therapeutics Announces Common Stock Purchase Agreement for up to $40 Million with Lincoln Park Capital
Provides Access to Additional Capital to Support Growth WARREN, N.J., April 13, 2022 (GLOBE NEWSWIRE)…
Applied Molecular Transport Announces Publication in Tissue Barriers Providing Additional Insight into Company’s Proprietary Technology Platform
Publication describes critical interactions between cholix-based transport domain and endogenous intracellular trafficking pathways used by…
Recce Pharmaceuticals Announces Phase I Clinical Trial of RECCE® 327 Advances to High Dosing Level
Dose increase of R327 Dose increase of R327 Highlights: 36 subjects successfully dosed in Phase…
Praxis Precision Medicines to Host Epilepsy Day on April 27, 2022
BOSTON, April 13, 2022 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage…
Baudax Bio to Present at NobleCon18 Investor Conference
MALVERN, Pa., April 13, 2022 (GLOBE NEWSWIRE) — Baudax Bio, Inc. (NASDAQ:BXRX), a pharmaceutical company…
Longeveron Enters into Cooperative Research and Development Agreement with the US Department of Veterans Affairs for its Phase 2 Alzheimer’s Trial
This third collaboration with the Miami VA shows Longeveron’s commitment to improving the health of…
Repligen to Report First Quarter 2022 Financial Results
Webcast and Conference Call to Be Held Wednesday, April 27, 2022 at 8:30 a.m. EDT…
Renowned Wound Care Key Opinion Leaders Presented Arch Therapeutics’ AC5® Advanced Wound System at 2022 Symposium on Advanced Wound Care (SAWC) Spring
Additional data covered a variety of specialties, including vascular surgery, plastic surgery, general surgery, and…
Theratechnologies Reports Financial Results for First Quarter Fiscal 2022 and Provides Business Update
– Q1 2022 consolidated sales grew 20%, supported by 35% growth in EGRIFTA SV®sales –…
iSpecimen Adds Acutis Diagnostics to Marketplace Platform to Support Oncology and Infectious Disease Research
The iSpecimen Marketplace Platform Now Provides Custom Sequencing for Cancer and COVID-19 Biofluid and Tissue…
ProQR Announces Additional Sepofarsen Illuminate Trial Analyses and Provides Update on Company Strategy
Post-hoc analyses from Illuminate trial of sepofarsen demonstrate an encouraging efficacy signal when comparing active…
HOOKIPA to Participate in the Kempen Life Sciences Conference
NEW YORK and VIENNA, Austria, April 13, 2022 (GLOBE NEWSWIRE) — HOOKIPA Pharma Inc. (NASDAQ:…
MeMed to host integrated symposium, oral presentation and poster spotlighting MeMed BV at the 32nd European Congress of Clinical Microbiology and Infectious Diseases Conference
MeMed to host integrated symposium, oral presentation and poster spotlighting MeMed BV at the 32ndEuropean…
SOPHiA GENETICS to Announce Financial Results for the First Quarter of Fiscal 2022 on May 10, 2022
BOSTON and LAUSANNE, Switzerland, April 13, 2022 (GLOBE NEWSWIRE) — SOPHiA GENETICS SA (Nasdaq: SOPH),…
Imcyse Announces First Patient Dosed in Adaptive Phase 1/2 Clinical Trial of Imotope™ IMCY-0141 for Multiple Sclerosis
IMCY-MS-001 study aims to determine safety profile, optimal dosing regimen and initial efficacy Second Imotope™…
VantAI Announces Multi-Year Protein Degrader Discovery Collaboration with Janssen
Zachary Carpenter Zachary Carpenter, Ph.D., Founder and CEO of VantAI NEW YORK, April 13, 2022…
Ikena Appoints Jotin Marango, M.D., Ph.D., as Chief Financial Officer and Head of Corporate Development
Dr. Marango brings years of valued experience in oncology biopharma business, finance, and corporate relations…